Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about AGNPF
Recent news which mentions AGNPF
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Tickers
AGNPF
ATAI
CMND
CMPS
Tags
ATAI
MNMD
Benzinga Psychedelics Podcast
From
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
April 03, 2024
Tickers
AGNPF
Tags
Psychedelics Research
Human Stroke
Management
From
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Tickers
AGNPF
ATAI
AWKNF
CMPS
Tags
OPTHF
Contracts
Penny Stocks
From
Benzinga
DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
August 08, 2023
Tickers
AGNPF
Tags
Markets
Cannabis
Market News
From
Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
June 05, 2023
Tickers
AGNPF
Tags
Management
Human Stroke
News
From
Benzinga
How To Finance A Psychedelics Business? Learn From These Four Companies
April 04, 2023
Tickers
AGNPF
CMND
PSYGF
Tags
Markets
PSYGF
News
From
Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
April 04, 2023
Tickers
AGNPF
Tags
DMT Entities
AGNPF
News
From
Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
Tickers
AGNPF
AWKNF
BRAXF
CMPS
Tags
Markets
CMPS
CYBN
From
Benzinga
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
March 03, 2023
Tickers
AGNPF
Tags
Benzinga
Penny Stocks
contributors
From
Benzinga
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
March 01, 2023
Tickers
AGNPF
IPOS
Tags
Psychedelics
Benzinga Psychedelics Capital Conference
Forward Stock Split
From
Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
Tickers
AGNPF
AWKNF
CMND
CYBN
Tags
Psychedelics Investing
PSYK
Financing
From
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Tickers
AGNPF
AWKNF
CYBN
DMTTF
Tags
Contracts
Global
Psychedelic/Assisted Therapies
From
Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
February 21, 2023
Tickers
AGNPF
TBI
Tags
DMT Entities
TBI
Psychedelics
From
Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
February 16, 2023
Tickers
AGNPF
Tags
Health Care
Psychedelics
DMT Entities
From
Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
January 18, 2023
Tickers
AGNPF
DMT
Tags
Market News
DMT
Cannabis
From
Benzinga
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
January 03, 2023
Tickers
AGNPF
Tags
AGN Neuro
Market News
Cannabis
From
Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
December 15, 2022
Tickers
AGNPF
ATAI
FLHLF
Tags
Top Stories
FLHLF
AGNPF
From
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Tickers
AGNPF
BMNDF
CMND
CMPS
Tags
PSIL
Market News
Cannabis
From
Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
November 16, 2022
Tickers
AGNPF
Tags
Psychedelics
Psychedelics Therapy
Strokes
From
Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
October 24, 2022
Tickers
AGNPF
Tags
Psychedelics
Market News
depression
From
Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
September 12, 2022
Tickers
AGNPF
DMT
Tags
AGNPF
News
Legal
From
Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
September 08, 2022
Tickers
AGNPF
Tags
Market News
Cannabis
Netherlands
From
Benzinga
Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
August 23, 2022
Tickers
AGNPF
Tags
Markets
Cannabis
Asset Sales
From
Benzinga
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
July 18, 2022
Tickers
AGNPF
Tags
General
Health Care
News
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
SILFF
WSNAF
SILO
From
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
Market News
SILO
WSNAF
From
Benzinga
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
September 13, 2021
Tickers
AGNPF
ALID
ATAI
FTRP
Tags
Penny Stocks
MYNDF
ALID
From
Benzinga
Investors Should Avoid High-Risk Atossa Therapeutics
August 02, 2021
Tickers
AGNPF
ATOS
GILD
LLY
Tags
ATOS
LLY
SRNE
From
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.